Review
Published on 20 Sep 2024
Advancing cancer therapy: new frontiers in targeting DNA damage response
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1474337
- 7,348 views
- 8 citations
Type at least 3 characters
23,751 articles
Original Research
Published on 20 Sep 2024
A real-world pharmacovigilance analysis of eslicarbazepine acetate using the FDA adverse events reporting system (FAERS) database from 2013 (Q4) to 2024 (Q1)
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1463560
- 2,995 views
- 1 citation
Mini Review
Published on 20 Sep 2024
Inflammation in a ferroptotic environment
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1474285
- 3,921 views
- 7 citations
Editorial
Published on 20 Sep 2024
Editorial: Molecular targets in oncological and hematological disease management: innovations in precision medicine
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494396
- 895 views
Methods
Published on 20 Sep 2024
A validated UPLC-MS/MS method for quantification of pyrotinib and population pharmacokinetic study of pyrotinib in HER2-positive breast cancer patients
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1432944
- 1,568 views
Systematic Review
Published on 20 Sep 2024
Meta-analysis of randomized controlled trials assessing the efficacy of nigella sativa supplementation for allergic rhinitis treatment
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1417013
- 3,938 views
- 2 citations
Original Research
Published on 20 Sep 2024
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1466824
- 2,947 views
Original Research
Published on 20 Sep 2024
Metabolomics and network pharmacology reveal partial insights into the hypolipidemic mechanisms of ferulic acid in a dyslipidemia mouse model
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1466114
- 2,227 views
Review
Published on 20 Sep 2024
Advances in the pharmacological mechanisms of berberine in the treatment of fibrosis
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1455058
- 3,261 views
- 1 citation
Correction
Published on 20 Sep 2024
Corrigendum: Nonmuscle myosin heavy chain IIA-mediated exosome release via regulation of the rho-associated kinase 1/myosin light chains/actin pathway
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1465932
- 718 views
Original Research
Published on 20 Sep 2024
Transdermal buprenorphine patch as an adjunct to multimodal analgesia after total joint arthroplasty: a retrospective cohort study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1412099
- 2,208 views
Original Research
Published on 20 Sep 2024
A quantitative systems pharmacology (QSP) platform for preclinical to clinical translation of in-vivo CRISPR-Cas therapy
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454785
- 5,268 views
- 1 citation
Review
Published on 20 Sep 2024
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1441938
- 2,051 views
Original Research
Published on 20 Sep 2024
Protective effect of MP-40 mitigates BDL-induced hepatic fibrosis by inhibiting the NLRP3-mediated pyroptosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1479503
- 2,250 views
- 1 citation
Mini Review
Published on 20 Sep 2024
Cardiovascular events in crush syndrome: on-site therapeutic strategies and pharmacological investigations
in Integrative and Regenerative Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472971
- 2,850 views
Original Research
Published on 20 Sep 2024
Improving the feasibility of deprescribing proton pump inhibitors: GPs’ insights on barriers, facilitators, and strategies
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468750
- 1,911 views